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Contrary to the common assumption that food has a negative impact on oral health, research has shown that several foods contain
a number of components with antibacterial and antiplaque activity. These natural compounds may be useful for improving daily
oral hygiene. In this study we evaluate the mode of antimicrobial action of fractions of mushroom and red chicory extracts on
Prevotella intermedia, a periodontopathogenic bacterium. The minimal inhibitory concentration corresponded to 0.5x compared
to the natural food concentration for both extracts. This concentration resulted in a bacteriostatic eﬀect in mushroom extract
and in a slightly bactericidal eﬀect in chicory extract. Cell mass continued to increase even after division stopped. As regards
macromolecular synthesis, DNA was almost totally inhibited upon addition of either mushroom or chicory extract, and RNA to
a lesser extent, while protein synthesis continued. Cell elongation occurred after septum inhibition as documented by scanning
electron microscopy and cell measurement. The morphogenetic eﬀects are reminiscent of the mode of action of antibiotics such
as quinolones or β-lactams. The discovery of an antibiotic-like mode of action suggests that these extracts can be advantageously
employed for daily oral hygiene in formulations of cosmetic products such as mouthwashes and toothpastes.
1. Introduction
Periodontal diseases include a sizeable group of pathological
alterations of the periodontal tissue. The commonest forms
of the disease are gingivitis and periodontitis, and these fig-
ure among the most widespread human infectious diseases
[1, 2]. Both are dental plaque-associated pathologies [3, 4].
Gingivitis is very common and is characterized by reversible
inflammation in the marginal periodontal tissues while peri-
odontitis is an inflammation-based infection of the support
structure of the teeth with progressive destruction of them
that can result in dental loss. The commonest form of perio-
dontitis is adult chronic periodontitis [1, 2]. Although several
factors including systemic pathologies such as diabetes and
immunosuppression or environmental factors such as smok-
ing are capable of contributing to the severity of periodontal
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diseases, bacterial infection is considered to be the leading
cause [5]. As far as adult chronic periodontitis is concerned,
the role of a bacterial consortium of the dental plaque, main-
ly composed of gram-negative strict anaerobes has been
demonstrated [5–7]. Prevotella intermedia is one of these
potential periodontopathogenic bacterial species. Several vir-
ulence factors including fimbriae, hydrolases, hemolysins,
hemagglutinins, and lipopolysaccharides have been detected
in this microorganism and confer bacterial coaggregation
capability, adhesion to epithelial cells, invasion of epithelial
cells, and induction of inflammatory lympho-, chemo-, and
cytokines [5, 8].
It is generally accepted that lowering the oral bacterial
biomass is an eﬀective method for curing and/or preventing
bacterial oral pathologies. The manual dexterity of many
individuals, however, is not eﬃcient enough for them to ob-
tain good oral hygiene, and therefore several methods have
been proposed in order to assist such people. The simpler the
methods are the more diﬀuse and eﬀective they prove. In
this context, products for regular daily oral hygiene such as
mouthwashes and toothpastes which contain compounds
endowed with antimicrobial and antiplaque activities are
considered excellent candidates.
Contrary to the commonly held opinion that food has
a negative impact on oral health, research conducted over
the past three decades has shown that several foods contain a
number of components endowed with antibacterial and
antiplaque activity [9, 10]. Very recently, it has been shown
that regular consumption of foods enriched with these
active molecules is associated with modification of the oral
microbial community in the direction of less periodon-
topathogenic microbiota [11]. It therefore seems reasonable
to encourage the consumption of such foods and/or to incor-
porate the active compound(s) in cosmetic products for daily
oral hygiene. Previous studies have shown antimicrobial and
antiplaque activities in low-molecular-mass (LMM) frac-
tions of extracts from both an edible mushroom (Lentinus
edodes, very popular in Japan and called shiitake) or from
Italian red chicory (early Treviso red chicory, an anthocyanic
cultivar of Cichorium intybus) [12, 13].
In this work we evaluate themode of antimicrobial action
of fractions of these two natural extracts on P. intermedia.
2. Materials andMethods
2.1. Bacterial Strain and Growth Conditions. P. intermedia
ATCC 25611 was used throughout this study. This strain was
grown in Brain Hearth Infusion (BHI, Oxoid Ltd., Bas-
ingstoke, UK) broth to which 5 μg/mL hemin and 1 μg/mL
vitamin K (Sigma-Aldrich Co., St. Louis, MO, USA) were
added (BHI+HK) or in Blood Agar (BA, Oxoid) plates.
Cultures in both liquid and solid media were incubated at
37◦C in an anaerobic chamber (Whitley DG 250 Anaerobic
Workstation, Don Whitley Scientific, Shipley, UK) with an
atmosphere composed of 85% nitrogen, 10% hydrogen, and
5% CO2. In some experiments growth of P. intermedia in
a biofilm structure was allowed on ceramic hydroxyapatite
(HA) discs (Clarkson Chromatography Products Inc., South
Williamsport, PA, USA). To achieve this, HA discs (2.5mm
diameter) were coated with sterile human saliva collected
from a pool of donors. Each disc was then incubated in 5mL
of BHI+HK medium spread with a P. intermedia culture in
a well of a 6-well tissue culture plate (35mm diameter, flat
bottom, Sarstedt, Verona, Italy) at 37◦C in the anaerobic
atmosphere. Every day (for a total of five days) culture super-
natants were removed by gentile aspiration and replaced with
fresh preconditioned medium. In order to analyse the ef-
fects of the test compound, on day 4 suitable dilutions of
LMM fractions of either mushroom or chicory extract were
added to the growth medium following incubation for an
additional 15 hours. At the end of each incubation, biofilms
were washed three times with sterile distilled water and then
fixed with 2.5% glutaraldehyde in 0.1M phosphate buﬀer pH
7.2 for SEM analysis.
2.2. LMM Fractions of Both Mushroom and Chicory Extracts.
Aqueous extracts of both shiitake mushroom and red chicory
and separation by ultrafiltration of the LMM (<5,000 Dal-
tons) fraction were performed as described elsewhere [13].
LMM fractions were lyophilised and stored up to 3months at
−80◦C. Immediately before use, a sample was rehydrated
with sterile distilled water to obtain a 10x solution and kept
at 4◦C for no longer than a week. The 1x concentration of the
LMM fraction after reconstitution represents the original
concentration in the food.
2.3. Evaluation of Cell Growth and Viability. Optical density
(O.D.) was measured at 640 nm wavelength with a Beck-
man mod. DU 530 spectrophotometer. Total bacteria were
counted as cell particles with a Coulter Counter mod ZBI
(Coulter Scientific) equipped with a 30 μm capillary. Viable
cells were determined as colony forming units (CFU) per mL
of culture. Suitable dilutions in sterile saline solution of the
untreated and treated cultures were plated in BA plates and
incubated at 37◦C for 48 hours in the anaerobic atmosphere.
2.4. Evaluation of DNA, RNA, and Protein Synthesis. Aliquots
of an exponentially growing culture (150 μL, O.D. 0.2 unit)
were placed in the wells of a microtitre plate together with
5 μCi of [3H] thymidine (spec. act. >10Ci/mmol) or [3H]
uridine (spec. act. >20Ci/mmol) or [3H] leucine (spec. act.
50 Ci/mmol, PerkinElmer Life and Analytical Science, Bos-
ton, MA, USA). In some wells suitable dilutions of the test
compounds were added. Each determination was performed
in triplicate. Microtiter plates were incubated at 37◦C in the
anaerobic atmosphere for 60min. At the end of this time
period the culture was overlaid on a Millipore GF/C glass
fibre paper soaked in advance with 10% trichloroacetic acid
(TCA) and plunged in a cold 10% TCA solution. Filters were
then washed three times with cold TCA and, finally, twice
with acetone. Radioactivity was determined with a Beckman
LS 6500 liquid scintillation counter. Three distinct identical
experiments were performed.
2.5. Scanning Electron Microscopy (SEM). SEM was per-
formed within a week of fixation of the samples. Glutar-
aldehyde-fixed samples from both planktonic and biofilm
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Table 1: Macromolecular synthesis of P. intermedia treated for 60min with diﬀerent concentrations of LMM fractions of both mushroom
and chicory extracts.
LMM fraction
Concentration Macromolecular synthesis (% of untreated control)
DNA RNA Protein
Mushroom
0 100b 100b 100b
0.25xa 19 47 83
0.5x 9 22 48
1x 5 5 36
Chicory
0 100c 100c 100c
0.25xa 22 53 79
0.5x 11 26 54
1x 8 4 32
a
Subinhibitory dose.
bControl values: DNA, 372,353 cpm; RNA, 147,367; protein, 12,682.
cControl values: DNA, 347,012 cpm; RNA, 129,647; protein, 11,239.
Table 2: Cell length measurement of P. intermedia cells treated for two hours with diﬀerent concentrations of LMM fraction of both
mushroom or chicory extracts in comparison with control cells at the same time.
Microorganism Growth condition
Cell length (μm)
Mean SD Min value Max value Mode
P. intermedia
Control 1.09 0.41 0.54 3.01 0.75
Mushroom 0.25xa 1.83 0.88 0.64 4.97 0.91
Mushroom 0.5x 1.94 1.09 0.72 7.40 1.38
Chicory 0.25xa 2.07 0.93 0.68 5.06 0.97
Chicory 0.5x 2.37 1.36 0.76 9.09 1.32
a
Subinhibitory dose.
cultures were washed three times with phosphate buﬀer
followed by three rinses in distilled water. Specimens were
then serially dehydrated in ethanol and subjected to critical-
point drying with CO2, mounted onmetal stubs and sputter-
coated with gold. Each specimen was viewed with an ESEM
FEG XL30 electron microscope (Fei-Philips) at magnifica-
tions of ×5,000 to ×40,000. Cell length measurement was
performed on 150 bacteria at ×5,000 magnification.
3. Results
3.1. Eﬀects of LMM Fractions of Both Mushroom and Chicory
Extracts on Cell Growth and Viability of P. intermedia.
Diﬀerent concentrations of the LMM fractions of both
mushroom and chicory extracts ranging from 0.25 to 1x were
tested in growing P. intermedia. Figure 1 shows the eﬀects
of these concentrations on increases in optical density, cell
particle number, and cell viability in P. intermedia. As far as
the LMM fraction of mushroom extract is concerned, the
concentration of 0.5x was the minimum dose capable of
inhibiting cell division, as evaluated by cell particle counts. At
this concentration a bacteriostatic eﬀect was observed, as well
as a slight increase in O.D. in the course of the experiment.
Higher concentrations (e.g., 1x) had a partial bactericidal
eﬀect with a 50% decrease in viable cells. Similar results were
obtained when LMM fraction of chicory extract was tested:
again theminimal dose capable of inhibiting cell division was
0.5x, but, as opposed to the same concentration of mush-
room extract, this concentration reduced cell viability by
50%.
3.2. Eﬀects of LMM Fractions of Both Mushroom and Chicory
Extracts on Macromolecular Synthesis of P. intermedia. DNA,
RNA and protein synthesis of P. intermedia were evaluated
in the presence of the active concentrations reported above.
Table 1 summarises the results: a strong inhibitory eﬀect on
DNA synthesis was observed during treatment with 1x and
0.5x concentrations of both mushroom and chicory extracts
with a residual synthesis lower than 10% of the untreated
control. The 0.25x subinhibitory concentration allowed
roughly 20% DNA synthesis. RNA synthesis, albeit to a
lesser extent compared with DNA synthesis, was reduced to
roughly 25% and 50% of the control in the presence of 1x
and 0.5x, respectively, no matter whether mushroom or chic-
ory was tested. The 1x concentration strongly inhibited RNA
synthesis. Protein synthesis was inhibited by 50% in the
presence of 0.5x while 1x induced greater inhibition (70%).
A reduction of only about 20% in protein synthesis was
observed at 0.25x.
3.3. Morphological Examination and Cell Size Distribution of
P. intermedia Treated with LMM Fractions of Mushroom and
Chicory Extracts. Bacteria treated as above were also collect-
ed for morphological analysis by both optical and scanning
electron microscopy (SEM). Preliminary observation by op-
tical microscopy showed the presence of elongated cells as a
result of the treatment. Thus, we resorted to SEM analysis in
order to precisely evaluate cell size and distribution. Figure 2
shows the appearance of P. intermedia during treatment
with mushroom or chicory extracts. Distinctly elongated
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Figure 1: Eﬀects on cell mass, cell number, and cell viability of P. intermedia treated with diﬀerent concentrations of LMM fraction of
mushroom (column (a)) and chicory (column (b)) extracts. Symbols: (♦) untreated control, () 0.25x, () 0.5x, () 1x concentration.
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Figure 2: Scanning electron microscopy of untreated P. intermedia (a) and after a three-hour treatment with 0.5x of LMM fraction of
mushroom (b) and chicory (c) extracts.
cells and several filaments with interrupted septa were seen
after a three-hour treatment while untreated control cells
prevalently presented the typical shape of short rods/cocco-
bacilli. Table 2 shows the mean cell lengths with additional
parameters of the treated cells in comparison with the
untreated ones. Cell measurements confirmed the mor-
phological observations at the inhibitory concentration.
However, it is worthy of note that elongation was also
observed in cells treated with a subinhibitory concentration
(0.25x). Furthermore, analysis of the size distribution of un-
treated control and treated P. intermedia cells confirmed
cell elongation following treatment (Figure 3). In a further
set of experiments we evaluated the eﬀects of the extracts
on P. intermedia biofilm architecture. Figure 4 shows that
untreated control biofilm appeared as a compact structure
with bacteria close to one another, while in treated biofilms,
both with mushroom and with chicory (the latter not shown
in the figure), several gaps were observable.
4. Discussion
A substantial number of in vitro studies have shown that
components of vegetal food exert intrinsic antibacterial, anti-
adhesive and antiplaque activity [9, 10]. The main family of
substances endowed with such activity is that of the polyphe-
nolic substances. These properties have been mainly detected
against oral bacteria, although microorganisms responsible
for infections of other human sites (e.g., lower urinary tract)
may interact with them [14, 15]. These observations suggest
that a diet rich in polyphenols may be useful for preventing
the development of oral microbial pathologies, especially
those known as plaque-dependent pathologies, such as caries
and gingivitis/periodontitis. Hence, the main repercussion
may be the development of so-called functional foods, that
is, foods enriched with healthy substances. At the same time
active compounds may be included in mouthwashes and
toothpastes for daily oral hygiene. Although a large number
of studies have been conducted to evaluate the eﬃcacy of
these compounds in terms of antimicrobial, antiadhesive,
and antiplaque activity, very little is known about their mode
of antibacterial action. The main goal of this research was
precisely to try to elucidate this aspect. Throughout the
study we used P. intermedia, one of the microorganisms
included in a polymicrobial complex (mainly composed
of strict anaerobe bacteria) which is involved in the eti-
ology of adult chronic periodontitis, a pathology present
worldwide and currently considered (together with dental
caries) the commonest infectious disease. We evaluated the
mechanism of antimicrobial action of LMM (<5,000Da)
fractions of aqueous extracts from bothmushroom (shiitake)
and red chicory [12, 13]. Test concentrations were referred
to the original food concentrations. The minimal active
concentration was 0.5x for both mushroom and chicory
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Figure 3: Cell length distribution of P. intermedia (a) and after a three-hour treatment with 0.5x chicory extract (b), and 0.5x (c) and 0.25x
(d) mushroom extracts.
extracts. This concentration of mushroom extract acted
bacteriostatically while the same concentration of chicory
extract was slightly bactericidal after a three-hour treatment.
At this concentration DNA synthesis was almost totally in-
hibited while RNA was inhibited to a lesser extent than DNA.
Protein synthesis was only partially inhibited. The persis-
tence of protein synthesis over time allows a cell mass
increase, as indicated by the increase in O.D., producing
cell filamentation, as revealed by SEM observation. In fact,
nonseptate long rods and filaments were observed after
treatment in comparison with untreated controls. These data
suggest that the main target of action of both mushroom
and chicory extracts is DNA synthesis. As a result of this, in-
hibition of septum formation occurs, but, as expected for
rod-shaped bacteria, elongation still occurs. Morphological
changes are compatible with the observation that protein
synthesis persists (about 50% of the untreated control) and
O.D. increases over time. This mode of action is reminiscent
of that described for antibiotics belonging to the quinolone
family (e.g., ciprofloxacin) [16]. These chemotherapeutic
agents primarily block DNA synthesis followed by septum
formation inhibition and cell filamentation. A similar mode
of action has been described for β-lactam antibiotics (e.g.,
penicillins and cephalosporins). In this case septum inhibi-
tion via blockade of the “penicillin binding protein” involved
in septum synthesis is the main target of action, and, in this
example too, filamentation occurs after septum inhibition
[17]. Thus, a mode of action comparable with that of antibi-
otics may be supposed for these natural extracts. This state-
ment is further supported by the observation that sub-MICs
display morphogenetic eﬀects such as those induced by the
MIC and higher doses, as previously demonstrated for both
β-lactams and quinolones [16, 18]. Thus, this preliminary
report indicates that a specific mode of action exists and
the identification of specific target(s) is needed. This result
suggests that these extracts could be used to advantage for
daily oral hygiene in formulations of cosmetic products
such as mouthwashes and toothpastes. The possibility of
developing cosmetic products in which the active compound
or compounds are natural molecules supports the tendency
of consumers to prefer natural compounds to those obtained
by chemical synthesis. Furthermore, foods enriched with
Journal of Biomedicine and Biotechnology 7
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Figure 4: Scanning electron microscopy of P. intermedia grown in biofilm state (a and b) and after treatment with 0.5x mushroom extract
(c and d).
these active compounds may be of great interest particularly
in developing countries where severer economic conditions
militate against the use of commercially available products
for regular oral hygiene.
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